Want to join the conversation?
$VRTX's operating costs and expenses for 1Q16 increased by 33% from last year. This increase was primarily due to increases in research and development expenses, sales, general and administrative expenses and cost of product revenues. In near term, $VRTX expects net loss (income) to be dependent on expected rises in Orkambi product revenues.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)